The Billion Dollar Bowl: How Drools Fed Its Way to India’s First Pet Food Unicorn

▴ The Billion Dollar Bowl
Drools, with its expanding influence, has the opportunity to set gold standards not just for business success, but also for how the pet food industry should behave i.e. responsibly, sustainably, and with genuine care.

There was a time when pet food in India meant kitchen leftovers or the occasional pack of biscuits shared generously under the table. Fast forward to today, and a silent revolution has unfolded right beneath our noses. It has fur, wagging tails, and a market size inching towards a billion dollar reality. At the center of this quiet storm stands Drools, an Indian pet food brand that has now taken the spotlight as the country’s very first unicorn in the pet care segment. In an industry often overshadowed by healthcare, technology, and finance headlines, this achievement is nothing short of pathbreaking.

Drools Pet Food Private Limited has recently stepped into the elite club of unicorns after receiving a significant strategic investment from Nestle S.A., the global giant behind the household brands we’ve grown up with. While the finer points of the deal remain closely guarded, the symbolic significance cannot be overstated. This partnership doesn't just mark a financial milestone, it cements Drools arrival on the global stage and positions India as a serious contender in the international pet care economy.

The story of Drools is more than a tale of capital and corporate milestones. It is a mirror reflecting the changing heart of urban India. Founded in 2010 by Fahim Sultan, the company started out with a vision rooted in one simple, almost sentimental belief that pets are family. And families deserve quality. What began as a fledgling idea has today matured into a robust enterprise with over 650 product varieties (SKUs), an expansive distribution across more than 40,000 retail shelves, and a growing presence in 22 countries.

But this moment was not born overnight. Just last year, Drools welcomed a substantial minority investment from private equity giant L Catterton, backed by none other than Louis Vuitton’s holding group. The $60 million injection helped Drools strengthen its backend, streamline operations, and widen its domestic dominance. With this foundation, the brand transformed. It went from being a pet food supplier to becoming the face of a broader lifestyle shift sweeping across urban India.

Today’s Indian pet parent is not the same as the one from a decade ago. They're informed, digital savvy, and emotionally invested. They browse ingredients, research dietary needs, and choose products that reflect their values. Drools tapped into this emerging psychology with precision. Backed by science driven formulations and a strong in house R&D emphasis, the company built products that weren’t just palatable, but purposeful. Pet health, much like human health, began getting the attention it long deserved.

And the numbers speak for themselves. With a workforce of 3,400 people, half of them actively driving sales on ground and six full fledged manufacturing plants, Drools now sits atop an operational empire spread across 1.6 million square feet of warehousing infrastructure. The company’s leadership had the foresight to invest in scale before the industry hit peak demand. That foresight is now paying dividends.

Drools unicorn status also marks an inflection point for India’s pet care industry, which until recently was treated more like a niche than a legitimate sector. Yet, the data tells a different story. India is currently one of the fastest growing pet markets globally, with an expected annual growth rate of 20% over the next five years. The sector is on track to cross $1.2 billion by 2028. This meteoric rise is not simply driven by numbers it’s being propelled by emotion, lifestyle, and a cultural reorientation that places pets firmly within the family fold.

Despite a relatively low penetration rate which is only about 10% of Indian households, the potential is massive. With increasing urbanization, nuclear families, mental health awareness, and rising disposable incomes, the pet adoption trend is catching on in cities, towns, and even rural pockets. The emotional void left by fast paced lives is increasingly being filled by four legged companions, and Drools is serving the essential role of ensuring those companions are not just fed, but well-nourished.

What makes Drools truly special, though, is that it didn’t rely on Western validation to find its footing. While the latest Nestle investment adds global clout, the company has always been deeply rooted in Indian sensibilities. It built its brand around affordability without compromising quality. It scaled without losing its agility. And perhaps most impressively, it grew by staying close to its consumers, whether that meant developing breed specific diets or working with veterinarians to tackle real health issues like obesity, digestion, and allergies in pets.

In a broader sense, Drools journey is a reflection of how Indian entrepreneurship is evolving. The company has combined manufacturing strength, scientific credibility, operational discipline, and emotional intelligence into a single growth engine. And now, with Nestle stepping in as a minority investor, the brand is poised to accelerate further, tapping into global supply chains, nutritional science expertise, and worldwide distribution networks.

But with growth comes responsibility. As more pets become a part of Indian households, the need for robust regulation, ethical marketing, and transparent labeling becomes even more critical. Drools, with its expanding influence, has the opportunity to set gold standards not just for business success, but also for how the pet food industry should behave i.e. responsibly, sustainably, and with genuine care.

Will Drools continue to innovate? Will it invest more in research? Will it venture into veterinary nutrition? Will it build on its export success and take the “Made in India” tag to more global shelves? The questions are many, but the confidence in its future is strong.

The road ahead will certainly be complex. Supply chains will need to adapt. Sustainability concerns will grow. Product diversification will become essential. But if the past decade has shown us anything, it’s that Drools has the vision and grit to evolve.

Tags : #Drools #PetCareUnicorn #PetCare #DroolsSuccessStory #IndianPetIndustry #PetIndustry #IndianInnovation #FundingSuccess #UnicornAlert #PetWellness #HealthyPets #PetHealth #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026